Status:

COMPLETED

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborating Sponsors:

Janssen, LP

Conditions:

Schizophrenia

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the efficacy (effectiveness of drug) and safety of the antipsychotic paliperidone ER compared to another antipsychotic, quetiapine, and to placebo in patients ...

Detailed Description

This is a randomized (patients are assigned different treatments based on chance), double blind (neither the patient nor the physician knows whether drug or placebo is being taken, or at what dosage),...

Eligibility Criteria

Inclusion

  • Diagnostic and Statistical Manual - Fourth Edition (DSM-IV) diagnosis of schizophrenia (paranoid, disorganized or undifferentiated type)
  • score of \>=4 on at least two of a subset of selected PANSS items and a total score on these five items of \>=17
  • score of \>=5 on the CGI-S (clinical global impression - severity)
  • body weight of at least 60kg and willing to be hospitalized for 9 days initially

Exclusion

  • A primary active mental illness diagnosis other than schizophrenia
  • subjects whose psychotic symptoms can be explained by substance intake or medical illness
  • pregnancy, breast-feeding, or planning to become pregnant
  • a history of treatment resistance (defined by failure to respond to 2 adequate trials of different antipsychotic medications or clozapine given at adequate dose for sufficient time)
  • unstable or significant medical illness that would increase risk of taking study medication or would confuse the interpretation of the study

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2007

Estimated Enrollment :

399 Patients enrolled

Trial Details

Trial ID

NCT00334126

Start Date

April 1 2006

End Date

September 1 2007

Last Update

May 18 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia | DecenTrialz